144 related articles for article (PubMed ID: 36288089)
1. Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy.
Butzner M; Maron MS; Sarocco P; Teng CC; Stanek E; Tan H; Robertson LA
J Invasive Cardiol; 2022 Dec; 34(12):E866-E872. PubMed ID: 36288089
[TBL] [Abstract][Full Text] [Related]
2. Differences in Short-Term Outcomes and Hospital-Based Resource Utilization Between Septal Reduction Strategies for Hypertrophic Obstructive Cardiomyopathy.
Yandrapalli S; Harikrishnan P; Andries G; Aronow WS; Panza JA; Naidu SS
J Invasive Cardiol; 2022 Jan; 34(1):E8-E13. PubMed ID: 34919530
[TBL] [Abstract][Full Text] [Related]
3. Survival After Septal Reduction in Patients >65 Years Old With Obstructive Hypertrophic Cardiomyopathy.
Mentias A; Smedira NG; Krishnaswamy A; Reed GW; Ospina S; Thamilarasan M; Popovic ZB; Xu B; Kapadia SR; Desai MY
J Am Coll Cardiol; 2023 Jan; 81(2):105-115. PubMed ID: 36631204
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States.
Jain SS; Li SS; Xie J; Sutton MB; Fine JT; Edelberg JM; Gao W; Spertus JA; Cohen DJ
J Med Econ; 2021; 24(1):1115-1123. PubMed ID: 34493144
[TBL] [Abstract][Full Text] [Related]
5. Healthcare resource utilization and cost of obstructive hypertrophic cardiomyopathy in a US population.
Butzner M; Maron M; Sarocco P; Teng CC; Stanek E; Tan H; Robertson L
Am Heart J Plus; 2022 Jan; 13():100089. PubMed ID: 38560082
[TBL] [Abstract][Full Text] [Related]
6. Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011.
Kim LK; Swaminathan RV; Looser P; Minutello RM; Wong SC; Bergman G; Naidu SS; Gade CL; Charitakis K; Singh HS; Feldman DN
JAMA Cardiol; 2016 Jun; 1(3):324-32. PubMed ID: 27438114
[TBL] [Abstract][Full Text] [Related]
7. In-hospital outcomes of septal myectomy vs. alcohol septal ablation for hypertrophic cardiomyopathy with outflow tract obstruction: An update and insights from the national inpatient sample from 2011 to 2019.
Inestroza K; Mijares-Rojas I; Matute-Martínez C; Ergui I; Albosta M; Vergara-Sanchez C; Dangl M; Hernandez RJ; Ebner B; Vincent LT; Maning J; Alfonso C; Colombo R
J Investig Med; 2024 Mar; 72(3):262-269. PubMed ID: 38185664
[TBL] [Abstract][Full Text] [Related]
8. Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.
Kimmelstiel C; Zisa DC; Kuttab JS; Wells S; Udelson JE; Wessler BS; Rastegar H; Kapur NK; Weintraub AR; Maron BJ; Maron MS; Rowin EJ
Circ Cardiovasc Interv; 2019 Jul; 12(7):e007673. PubMed ID: 31296080
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 Years.
Lemor A; Villablanca PA; Hosseini Dehkordi SH; Mand R; Hernandez GA; Jain T; Blumer VL; Lee J; Eng M; Guerrero M; Wang DD; Palacios I; O'Neill W
Am J Cardiol; 2020 Jul; 127():128-134. PubMed ID: 32402483
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Surgical Ventricular Septal Reduction to Alcohol Septal Ablation Therapy in Patients with Hypertrophic Cardiomyopathy.
Bourque C; Réant P; Bernard A; Leroux L; Bonnet G; Pernot M; Bisson A; Herbert J; Saint-Etienne C; Lafitte S; Fauchier L
Am J Cardiol; 2022 Jun; 172():109-114. PubMed ID: 35351287
[TBL] [Abstract][Full Text] [Related]
11. Mortality After Alcohol Septal Ablation vs. Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.
Yasuda R; Osawa I; Goto T; Hasegawa K; Fifer MA; Tower-Rader A; Reilly MP; Maurer MS; Zhao Y; Takayama H; Shimada YJ
Circ Rep; 2024 Mar; 6(3):74-79. PubMed ID: 38464986
[No Abstract] [Full Text] [Related]
12. [Efficacy of alcohol septal ablation in mildly symptomatic or severely symptomatic patients with hypertrophic obstructive cardiomyopathy].
Sun JJ; Li PJ; Yu XP; Zhao H; Zhang XL; Tu CC; Zhang MD; Jiang TY; Song XT; He JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 May; 51(5):513-520. PubMed ID: 37198123
[No Abstract] [Full Text] [Related]
13. Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation.
Yang Q; Zhu C; Cui H; Tang B; Wang S; Yu Q; Zhao S; Song Y; Wang S
J Thorac Dis; 2021 Feb; 13(2):1055-1065. PubMed ID: 33717578
[TBL] [Abstract][Full Text] [Related]
14. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
Poon SS; Field M; Gupta D; Cameron D
Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
[TBL] [Abstract][Full Text] [Related]
15. Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
Cui H; Schaff HV; Wang S; Lahr BD; Rowin EJ; Rastegar H; Hu S; Eleid MF; Dearani JA; Kimmelstiel C; Maron BJ; Nishimura RA; Ommen SR; Maron MS
J Am Coll Cardiol; 2022 May; 79(17):1647-1655. PubMed ID: 35483751
[TBL] [Abstract][Full Text] [Related]
16. Septal Myectomy or Alcohol Ablation for Hypertrophic Cardiomyopathy: A Nationwide Inpatient Sample (NIS) Database Analysis.
Ullah W; Warner E; Khandait H; Sachdeva S; Abdalla AS; Shafique M; Khan MA; Roomi S; Khattak F; Alraies MC
Cardiovasc Revasc Med; 2023 May; 50():54-58. PubMed ID: 36737383
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Cost of Septal Myectomy Versus Alcohol Septal Ablation for Hypertrophic Cardiomyopathy.
Sun D; Schaff HV; Van Houten HK; Nguyen A; Sangaralingham LR; Nishimura RA; Geske JB; Dearani JA; Ommen SR
Mayo Clin Proc; 2022 Sep; 97(9):1656-1663. PubMed ID: 36058579
[TBL] [Abstract][Full Text] [Related]
18. Septal myectomy for hypertrophic cardiomyopathy: important surgical knowledge and technical tips in the era of increasing alcohol septal ablation.
Chiang YP; Shimada YJ; Ginns J; Weiner SD; Takayama H
Gen Thorac Cardiovasc Surg; 2018 Apr; 66(4):192-200. PubMed ID: 29450766
[TBL] [Abstract][Full Text] [Related]
19. Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.
Osman M; Kheiri B; Osman K; Barbarawi M; Alhamoud H; Alqahtani F; Alkhouli M
Clin Cardiol; 2019 Jan; 42(1):190-197. PubMed ID: 30421437
[TBL] [Abstract][Full Text] [Related]
20. A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy.
Singh K; Qutub M; Carson K; Hibbert B; Glover C
Catheter Cardiovasc Interv; 2016 Jul; 88(1):107-15. PubMed ID: 26526299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
